SCHEMBL26217430

SCHEMBL26217430

CCN(CC(=O)N(C)c1ccc(OC)cc1)c1ccc(Cl)c(Cl)c1

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CETP P11597 1/20 0.43
S1PR1 P21453 1/20 0.41
LMNA P02545 2/20 0.40
HCRTR2 O43614 1/20 0.40
ALDH1A1 P00352 1/20 0.40
HSP90AA1 P07900 1/20 0.40
PDK1 Q15118 1/20 0.40
PDK2 Q15119 1/20 0.40
PDK3 Q15120 1/20 0.40
PDK4 Q16654 1/20 0.40
TP53 P04637 1/20 0.39
POLB P06746 1/20 0.39
MAPT P10636 1/20 0.39
MCHR1 Q99705 2/20 0.39
PPIB P23284 1/20 0.39
KMT2A Q03164 1/20 0.39
PPARG P37231 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26217594 0.90 ALDH1A1 (0.46) CETPLMNAALDH1A1HSP90AA1PDK1
SCHEMBL26264794 0.88 CETP (0.44) CETPLMNAALDH1A1HSP90AA1PDK1
SCHEMBL26217555 0.87 L3MBTL1 (0.48) S1PR1LMNAALDH1A1MAPTKMT2A
SCHEMBL26217468 0.87 ALDH1A1 (0.47) LMNAALDH1A1HSP90AA1PDK1PDK2
SCHEMBL26217412 0.85 BCL2A1 (0.47) LMNATP53POLBMAPTMCHR1
SCHEMBL26217576 0.84 AHCY (0.42) LMNAHCRTR2ALDH1A1HSP90AA1PDK1
SCHEMBL26217384 0.82 LMNA (0.51) LMNAALDH1A1TP53POLBMAPT
SCHEMBL26217618 0.80 LMNA (0.41) LMNATP53POLBMAPT
SCHEMBL26222016 0.79 ALDH1A1 (0.45) CETPLMNAALDH1A1HSP90AA1PDK1
SCHEMBL26217525 0.78 HSD17B1 (0.43) CETPLMNAALDH1A1TP53POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230399292-A1 ANESTHETIC COMPOUNDS AND METHODS OF MAKING AND USING SAME TO TREAT OR PREVENT PAIN SYMPTOMS PTC Innovations, LLC 2023-12-14 US disclosed
US-20230399291-A1 ANESTHETIC COMPOUNDS AND METHODS OF MAKING AND USING SAME TO TREAT OR PREVENT PAIN SYMPTOMS PTC INNOVATIONS LLC (US) 2023-12-14 US disclosed
US-20230399290-A1 ANESTHETIC COMPOUNDS AND METHODS OF MAKING AND USING SAME TO TREAT OR PREVENT PAIN SYMPTOMS PTC INNOVATIONS LLC (US) 2023-12-14 US disclosed
US-20230373906-A1 ANESTHETIC COMPOUNDS AND METHODS OF MAKING AND USING SAME TO TREAT OR PREVENT PAIN SYMPTOMS PTC INNOVATIONS LLC (US) 2023-11-23 US disclosed
US-11814335-B1 Anesthetic compounds and methods of making and using same to treat or prevent pain symptoms PTC Innovations, LLC (US) 2023-11-14 US disclosed
US-11786493-B2 Anesthetic compounds and methods of making and using same to treat or prevent pain symptoms PTC Innovations, LLC (US) 2023-10-17 US disclosed
WO-2023172603-A1 ANESTHETIC COMPOUNDS AND METHODS OF MAKING AND USING SAME TO TREAT OR PREVENT PAIN SYMPTOMS PTC Innovations, LLC (US) 2023-09-14 WO disclosed
US-20230286905-A1 ANESTHETIC COMPOUNDS AND METHODS OF MAKING AND USING SAME TO TREAT OR PREVENT PAIN SYMPTOMS PTC Innovations, LLC 2023-09-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230399290-A1 ANESTHETIC COMPOUNDS AND METHODS OF MAKING AND USING SAME TO TREAT OR PREVENT PAIN SYMPTOMS OPRK1, ACHE, F5 CETP 421/4885S1PR1 1494/4885LMNA 2285/4885
US-20230399292-A1 ANESTHETIC COMPOUNDS AND METHODS OF MAKING AND USING SAME TO TREAT OR PREVENT PAIN SYMPTOMS OPRM1, OPRL1, OPRK1 CETP 1911/4885S1PR1 3000/4885LMNA 2668/4885
US-20230399291-A1 ANESTHETIC COMPOUNDS AND METHODS OF MAKING AND USING SAME TO TREAT OR PREVENT PAIN SYMPTOMS CHRM2, RXFP2, OPRM1 CETP 2306/4885S1PR1 2034/4885LMNA 3130/4885
US-11814335-B1 Anesthetic compounds and methods of making and using same to treat or prevent pain symptoms F8, F5, OPRM1 CETP 359/4885S1PR1 1662/4885LMNA 2286/4885
US-20230286905-A1 ANESTHETIC COMPOUNDS AND METHODS OF MAKING AND USING SAME TO TREAT OR PREVENT PAIN SYMPTOMS OPRM1, OPRL1, OPRK1 CETP 548/4885S1PR1 1537/4885LMNA 3532/4885
US-20230373906-A1 ANESTHETIC COMPOUNDS AND METHODS OF MAKING AND USING SAME TO TREAT OR PREVENT PAIN SYMPTOMS F5, EIF4G2, ACHE CETP 491/4885S1PR1 1550/4885LMNA 2318/4885
US-11786493-B2 Anesthetic compounds and methods of making and using same to treat or prevent pain symptoms OPRM1, OPRL1, OPRK1 CETP 548/4885S1PR1 1537/4885LMNA 3532/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.